MRF.NS(MRF.NS)
MRF.NS
No analyst ratings available
No analyst price targets available for MRF.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $345.67B | $375.72B | $399.16B |
| Low | $338.32B | $359.65B | $385.95B |
| High | $358.82B | $392.44B | $406.10B |
| EBITDA Avg | $53.06B | $63.80B | $72.83B |
| Low | $49.44B | $60.72B | $69.20B |
| High | $55.39B | $70.76B | $76.10B |
| EBIT Avg | $33.37B | $41.88B | $48.76B |
| Low | $29.75B | $38.81B | $45.13B |
| High | $35.70B | $48.85B | $52.03B |
| Net Income Avg | $22.07B | $28.39B | $33.49B |
| Low | $19.39B | $26.11B | $30.80B |
| High | $23.80B | $33.55B | $35.92B |
| EPS Avg | $5047.95 | $6687.24 | $7776.82 |
| Low | $4570.93 | $6155.86 | $7262.17 |
| High | $5611.79 | $7911.95 | $8469.15 |
| Analysts (Rev / EPS) | 8 / 6 | 8 / 8 | 4 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $82.22B | $88.36B | $87.03B |
| Low | $82.22B | $88.36B | $87.03B |
| High | $82.22B | $88.36B | $87.03B |
| EBITDA Avg | $10.89B | $12.53B | $13.15B |
| Low | $10.89B | $12.53B | $13.15B |
| High | $10.89B | $12.53B | $13.15B |
| EBIT Avg | $6.30B | $7.81B | $8.30B |
| Low | $6.30B | $7.81B | $8.30B |
| High | $6.30B | $7.81B | $8.30B |
| Net Income Avg | $4.01B | $5.13B | $5.50B |
| Low | $4.01B | $5.13B | $5.50B |
| High | $4.01B | $5.13B | $5.50B |
| EPS Avg | $946.40 | $1210.40 | $1297.40 |
| Low | $946.40 | $1210.40 | $1297.40 |
| High | $946.40 | $1210.40 | $1297.40 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |